spacer
home > pmps > autumn 2008 > rubber stoppers: delivering safe sterile components
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Rubber Stoppers: Delivering Safe Sterile Components

Supplying ‘ready-to-use’ primary packaging components is the logical follow-up to supplying ‘ready-to-sterilise’ components. By transferring washing and sterilisation operations to the supplier, this concept gives greater flexibility to pharmaceutical laboratories. Delegating a key operation like sterilisation requires the highest degree of quality assurance, and it is the responsibility of the supplier to guarantee the sterility of the parts it supplies. Obtaining sterile components requires mastery of all the applicable pharmaceutical requirements, control over the process before irradiation, and a validation procedure to ensure effective sterilisation.

MASTERY OF THE PRODUCTION PROCESS BEFORE IRRADIATION

Sterile, ‘ready-to-use’ products, whether stoppers or plungers, undergo a specific manufacturing process before being sterilised by gamma radiation...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

Arcis Biotechnology and Mirnax Biosens sign exclusive license agreement for Arcis sample prep technology

Daresbury, UK, and Madrid, Spain, 16 July 2019: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, and Mirnax Biosens (“Mirnax”), the developer of microRNA (miRNA) biomarkers for clinical diagnostics, today announced they have signed an exclusive license agreement for use of Arcis sample preparation and preservation technology.
More info >>

White Papers

Delivering Fit For Purpose Biomanufacturing CHO Cell Lines

Fujifilm Diosynth Biotechnologies

The challenge during mammalian cell line development is to identify and isolate stable, high expressing cell lines producing product with the appropriate critical product quality attributes rapidly, reproducibly and with relative ease. Obtaining a host cell line that inherently exhibits desirable biomanufacturing attributes can therefore have a significantly positive effect on the identification of recombinant cell lines with desired traits during cell line development screens. In this study, we demonstrate that it is possible to exploit intrinsic heterogeneity within host cell populations and identify host cell lines which are more “fit for purpose”.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement